English  |  正體中文  |  简体中文  |  Total items :2851814  
Visitors :  44855182    Online Users :  1411
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"tseng l h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 86-135 of 253  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-06-19T02:38:41Z Human T-lymphotropic virus type II infection in Vietnamese thalassemic patients Lin M.T.;Nguyen B.T.;Binh T.V.;Be T.V.;Chiang T.Y.;Tseng L.H.;Ya-Chien Yang;Lin K.H.;Chen Y.C.; Lin M.T.; Nguyen B.T.; Binh T.V.; Be T.V.; Chiang T.Y.; Tseng L.H.; YA-CHIEN YANG; Lin K.H.; Chen Y.C.
臺大學術典藏 2020-06-19T02:38:41Z Subtyping of human T-lymphotropic virus type I by amplification of long terminal repeat sequences and restriction fragment length polymorphism analysis in carriers with multiple transfusions Lin M.-T.;Ya-Chien Yang;Chen P.-J.;Tang J.-L.;Tseng L.-H.;Wang C.-W.;Chen Y.-C.; Lin M.-T.; YA-CHIEN YANG; Chen P.-J.; Tang J.-L.; Tseng L.-H.; Wang C.-W.; Chen Y.-C.
臺大學術典藏 2020-06-19T02:38:40Z Familial transmission of human T-lymphocyte virus type (HTLV-1) in patients with adult T-cell leukemia/lymphoma or HTLV-1-associated myelopathy Yang C.-S.;Chen Y.-C.;Wang C.-H.;Tseng L.-H.;Tang J.-L.;YA-CHIEN YANG;Lin M.-T.;Hu C.-Y.; Hu C.-Y.; Lin M.-T.; YA-CHIEN YANG; Tang J.-L.; Tseng L.-H.; Wang C.-H.; Chen Y.-C.; Yang C.-S.
臺大學術典藏 2020-06-16T07:53:31Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Liang-In Lin;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; LIANG-IN LIN; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-06-16T07:53:29Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Liang-In Lin;Yeh K.-H.;Jeng Y.-M.; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; LIANG-IN LIN; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏 2020-06-16T07:53:23Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Chen K.-H.;Liang-In Lin;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; LIANG-IN LIN; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-04-24T01:34:13Z Prediction Model for Audiological Outcomes in Patients With GJB2 Mutations Hsu C.-J.; Chen-Chi Wu; Chen P.-Y.; Lin Y.-H.; Liu T.-C.; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; Chen P.-L.
臺大學術典藏 2020-03-09T09:11:13Z Prediction Model for Audiological Outcomes in Patients With GJB2 Mutations Chen P.-Y.; Lin Y.-H.; TIEN-CHEN LIU; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; Chen P.-L.; Wu C.-C.; Hsu C.-J.
臺大學術典藏 2020-03-07T06:56:33Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏 2020-03-07T06:56:33Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-07T06:56:25Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liau J.-Y.; Liang J.-T.; Tsai J.-H.; Liang Y.-H.; Lin Y.-.; Lin Y.-.;Liang Y.-H.;Tsai J.-H.;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.
臺大學術典藏 2020-03-07T06:56:23Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Yih-Leong Chang;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-07T06:56:18Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.; Chen K.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Yih-Leong Chang;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.
臺大學術典藏 2020-03-07T06:42:09Z Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression Huang H.-N.;Lin M.-C.;Tseng L.-H.;Chiang Y.-C.;Lin L.-I.;Lin Y.-F.;Huang H.-Y.;Kuan-Ting Kuo; Huang H.-Y.; KUAN-TING KUO; Lin L.-I.; Lin Y.-F.; Chiang Y.-C.; Tseng L.-H.; Lin M.-C.; Huang H.-N.
臺大學術典藏 2020-03-07T06:42:08Z Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences Mao T.-L.;Ayhan A.;Kuan-Ting Kuo;Lin M.-C.;Tseng L.-H.;Ogawa H.; Mao T.-L.; Ayhan A.; KUAN-TING KUO; Lin M.-C.; Tseng L.-H.; Ogawa H.
臺大學術典藏 2020-03-07T06:42:06Z Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis Hsiue E.H.-C.;Hsu C.;Tseng L.-H.;Lu T.-P.;Kuan-Ting Kuo; Hsiue E.H.-C.; Hsu C.; Tseng L.-H.; Lu T.-P.; KUAN-TING KUO
臺大學術典藏 2020-03-06T08:25:01Z Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Liau J.-Y.;Yung-Ming Jeng; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; YUNG-MING JENG
臺大學術典藏 2020-03-06T08:24:56Z RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy Tsai J.-H.; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; YUNG-MING JENG
臺大學術典藏 2020-03-06T08:24:55Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; YUNG-MING JENG
臺大學術典藏 2020-03-06T05:26:20Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T05:26:15Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-06T05:26:12Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-06T05:26:09Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T12:32:49Z Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences TSUI-LIEN MAO; Ayhan A.; Kuo K.-T.; Lin M.-C.; Tseng L.-H.; Ogawa H.
臺大學術典藏 2020-03-05T12:22:25Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T12:22:25Z KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L.
臺大學術典藏 2020-03-05T07:52:33Z Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression Huang H.-N.; Lin M.-C.; Tseng L.-H.; Chiang Y.-C.; Lin L.-I.; Lin Y.-F.; Huang H.-Y.; KUAN-TING KUO
臺大學術典藏 2020-03-05T07:52:30Z Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: Implications for pathogenetic and survival differences Ogawa H.; Tseng L.-H.; Mao T.-L.; Ayhan A.; KUAN-TING KUO; Lin M.-C.
臺大學術典藏 2020-03-05T07:52:28Z Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis Hsiue E.H.-C.; Hsu C.; Tseng L.-H.; Lu T.-P.; KUAN-TING KUO
臺大學術典藏 2020-03-05T07:31:48Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T07:31:46Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S.
臺大學術典藏 2020-03-05T07:31:45Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T07:31:45Z RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy JIA-HUEI TSAI; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M.
臺大學術典藏 2020-03-05T07:31:45Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Jia-Huei Tsai;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Jeng Y.-M.; JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏 2020-03-05T06:28:43Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.
臺大學術典藏 2020-03-05T06:28:40Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU
臺大學術典藏 2020-03-05T06:28:37Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-03-05T06:28:37Z Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Jau-Yu Liau;Jeng Y.-M.; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; JAU-YU LIAU; Jeng Y.-M.
臺大學術典藏 2020-03-05T06:28:34Z RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy Tsai J.-H.; JAU-YU LIAU; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M.
臺大學術典藏 2020-03-05T06:28:33Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-03-05T06:28:33Z Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome Tsai J.-H.; JAU-YU LIAU; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M.
臺大學術典藏 2020-03-05T06:28:28Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-02-25T05:15:28Z Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-02-25T05:15:26Z Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.
臺大學術典藏 2020-02-25T05:15:25Z BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.
臺大學術典藏 2020-02-25T05:15:25Z Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2020-02-24T02:29:11Z CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; BEEN-REN LIN; Cheng A.-L.; Yeh K.-H.; Chen K.-H.; Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Been-Ren Lin;Cheng A.-L.;Yeh K.-H.
臺大學術典藏 2020-02-17T08:07:45Z Selective reduction of multiple pregnancies in the first trimester or early second trimester. Ko T.M;Yu-Shih Yang;Hsieh F.J;Ho H.N;Liu C.H;Tseng L.H;Chen H.Y;Lee T.Y.; Ko T.M; YU-SHIH YANG; Hsieh F.J; Ho H.N; Liu C.H; Tseng L.H; Chen H.Y; Lee T.Y.
臺大學術典藏 2020-02-17T08:07:42Z Norplant-2 subdermal contraceptive system: Experience in Taiwan Lee T.-Y;Yu-Shih Yang;Tseng L.-H;Ko T.-M;Hsu M.-C;Chuang S.-M.; Lee T.-Y; YU-SHIH YANG; Tseng L.-H; Ko T.-M; Hsu M.-C; Chuang S.-M.
臺大學術典藏 2020-02-17T08:07:36Z Norplant? subdermal contraceptive system: Experience in Taiwan Tseng L.-H;Lee T.-Y;Yu-Shih Yang;Ko T.-M;Chuang S.-M.; Tseng L.-H; Lee T.-Y; YU-SHIH YANG; Ko T.-M; Chuang S.-M.

Showing items 86-135 of 253  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page